Urbonavicius J, cekyte A, Tauraite D
Int J Mol Sci. 2025; 26(5).
PMID: 40076440
PMC: 11898903.
DOI: 10.3390/ijms26051812.
Kvach M, Harjes S, Kurup H, Jameson G, Harjes E, Filichev V
Beilstein J Org Chem. 2024; 20:1088-1098.
PMID: 38774272
PMC: 11106675.
DOI: 10.3762/bjoc.20.96.
Kurup H, Kvach M, Harjes S, Jameson G, Harjes E, Filichev V
Org Biomol Chem. 2023; 21(24):5117-5128.
PMID: 37282621
PMC: 10282898.
DOI: 10.1039/d3ob00392b.
Urbeliene N, Tiskus M, Tamulaitiene G, Gasparaviciute R, Lapinskaite R, Jauniskis V
Sci Adv. 2023; 9(5):eade4361.
PMID: 36735785
PMC: 9897663.
DOI: 10.1126/sciadv.ade4361.
Maiti A, Hedger A, Myint W, Balachandran V, Watts J, Schiffer C
Nat Commun. 2022; 13(1):7117.
PMID: 36402773
PMC: 9675756.
DOI: 10.1038/s41467-022-34752-1.
Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
Hong K, Tagnedji A, Doll M, Walls K, Hein D
J Cancer Res Clin Oncol. 2022; 149(8):5047-5060.
PMID: 36329350
PMC: 10193532.
DOI: 10.1007/s00432-022-04436-w.
U-to-C RNA editing by synthetic PPR-DYW proteins in bacteria and human culture cells.
Ichinose M, Kawabata M, Akaiwa Y, Shimajiri Y, Nakamura I, Tamai T
Commun Biol. 2022; 5(1):968.
PMID: 36109586
PMC: 9478123.
DOI: 10.1038/s42003-022-03927-3.
An Engineered Cytidine Deaminase for Biocatalytic Production of a Key Intermediate of the Covid-19 Antiviral Molnupiravir.
Burke A, Birmingham W, Zhuo Y, Thorpe T, Zucoloto da Costa B, Crawshaw R
J Am Chem Soc. 2022; 144(9):3761-3765.
PMID: 35224970
PMC: 8915250.
DOI: 10.1021/jacs.1c11048.
DYW domain structures imply an unusual regulation principle in plant organellar RNA editing catalysis.
Takenaka M, Takenaka S, Barthel T, Frink B, Haag S, Verbitskiy D
Nat Catal. 2021; 4(6):510-522.
PMID: 34712911
PMC: 7611903.
DOI: 10.1038/s41929-021-00633-x.
MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism.
Olou A, King R, Yu F, Singh P
Oncogene. 2020; 39(16):3381-3395.
PMID: 32103170
PMC: 7165067.
DOI: 10.1038/s41388-020-1225-4.
The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?.
Frances A, Cordelier P
Mol Ther. 2019; 28(2):357-366.
PMID: 31870623
PMC: 7001087.
DOI: 10.1016/j.ymthe.2019.11.026.
APOBEC Enzymes as Targets for Virus and Cancer Therapy.
Olson M, Harris R, Harki D
Cell Chem Biol. 2017; 25(1):36-49.
PMID: 29153851
PMC: 5775913.
DOI: 10.1016/j.chembiol.2017.10.007.
Zebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells.
Nakamura K, Aizawa K, Aung K, Yamauchi J, Tanoue A
Sci Rep. 2017; 7:41093.
PMID: 28112215
PMC: 5253741.
DOI: 10.1038/srep41093.
Discovery of a bacterial 5-methylcytosine deaminase.
Hitchcock D, Fedorov A, Fedorov E, Almo S, Raushel F
Biochemistry. 2014; 53(47):7426-35.
PMID: 25384249
PMC: 4255641.
DOI: 10.1021/bi5012767.
Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels.
Funamizu N, Lacy C, Fujita K, Furukawa K, Misawa T, Yanaga K
PLoS One. 2012; 7(5):e37424.
PMID: 22616006
PMC: 3353937.
DOI: 10.1371/journal.pone.0037424.
Contrasting behavior of conformationally locked carbocyclic nucleosides of adenosine and cytidine as substrates for deaminases.
Marquez V, Schroeder G, Ludek O, Siddiqui M, Ezzitouni A, Wolfenden R
Nucleosides Nucleotides Nucleic Acids. 2010; 28(5):614-32.
PMID: 20183605
PMC: 2910114.
DOI: 10.1080/15257770903091904.
Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.
Beumer J, Eiseman J, Parise R, Florian Jr J, Joseph E, DArgenio D
Cancer Chemother Pharmacol. 2007; 62(3):457-64.
PMID: 18008070
PMC: 2677692.
DOI: 10.1007/s00280-007-0625-2.
Testing electrostatic complementarity in enzyme catalysis: hydrogen bonding in the ketosteroid isomerase oxyanion hole.
Kraut D, Sigala P, Pybus B, Liu C, Ringe D, Petsko G
PLoS Biol. 2006; 4(4):e99.
PMID: 16602823
PMC: 1413570.
DOI: 10.1371/journal.pbio.0040099.
Mice deficient in APOBEC2 and APOBEC3.
Mikl M, Watt I, Lu M, Reik W, Davies S, Neuberger M
Mol Cell Biol. 2005; 25(16):7270-7.
PMID: 16055735
PMC: 1190257.
DOI: 10.1128/MCB.25.16.7270-7277.2005.
Fourier transform ion cyclotron resonance MS reveals the presence of a water molecule in an enzyme transition-state analogue complex.
Borchers C, Marquez V, Schroeder G, Short S, Snider M, Speir J
Proc Natl Acad Sci U S A. 2004; 101(43):15341-5.
PMID: 15494437
PMC: 524446.
DOI: 10.1073/pnas.0406781101.
